Aktuelle Urologie

LinksSchließen

Referenz

Agarwal N, Chowdhury S, Bjartell A. et al.
Time to second progression (PFS2) in patients (pts) from TITAN with metastatic castration-sensitive prostate cancer (mCSPC) by first subsequent therapy (hormonal vs. taxane).

J Clin Oncol 2020;
38 (Suppl. 06) 82

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: